Central Nervous System Diseases
QYNAPSE Novel Imaging Software for Central Nervous System Diseases Receives FDA Clearance
QyScore® allows automated quantification of a broad portfolio of Magnetic Resonance Imaging markers that are key to support early diagnosis and clinical monitoring of neurodegenerative disorders notes QYNAPSE.
